Braunstein Neil A
Division of Rheumatology, Southwest Medical Associates, 5580 W Flamingo Rd. Ste. 105, Las Vegas, NV 89103, United States.
Bone Rep. 2015 Oct 30;4:1-4. doi: 10.1016/j.bonr.2015.10.005. eCollection 2016 Jun.
Hypophosphatasia (HPP) is a rare, inherited metabolic bone disease resulting from mutations in the gene encoding tissue non-specific alkaline phosphatase. The biochemical hallmark and key diagnostic indicator is low alkaline phosphatase activity, which leads to a variety of clinical manifestations across all ages. The diagnosis is easily missed in adults, who frequently present with nonspecific clinical manifestations such as fractures, osteomalacia, and pain. Here, the pathway to diagnosis and disease course is described in an adult patient presenting with pain. Low serum alkaline phosphatase activity went unnoticed for 2 years until osteomalacia was suspected, during which time he experienced multiple fractures and progressing pain. Currently, accumulated morbidity has rendered the patient unable to work, and treatment is focused on pain management. This case highlights the importance of low alkaline phosphatase in the differential diagnosis of patients with musculoskeletal pain.
低磷酸酯酶症(HPP)是一种罕见的遗传性代谢性骨病,由编码组织非特异性碱性磷酸酶的基因突变引起。生化标志和关键诊断指标是碱性磷酸酶活性降低,这会导致各年龄段出现多种临床表现。在成人中很容易漏诊,他们常表现为骨折、骨软化症和疼痛等非特异性临床表现。在此,描述了一名以疼痛就诊的成年患者的诊断途径和病程。血清碱性磷酸酶活性低在2年内未被注意到,直到怀疑有骨软化症,在此期间他经历了多次骨折且疼痛不断加重。目前,累积的发病率已使患者无法工作,治疗重点是疼痛管理。该病例突出了低碱性磷酸酶在肌肉骨骼疼痛患者鉴别诊断中的重要性。